Anzeige
Mehr »
Login
Montag, 25.10.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Analysten heben Kursziel massiv an! Chance auf über +140%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrAtreca, Gates MRI partner to develop antibody for malaria prevention
DoBeiGene's Brukinsa receives approval to treat mantle cell lymphoma in Russia
MiAmgen completes acquisition of biotechnology firm Teneobio
MiMoleculin receives MHRA approval for Phase Ia trial of WP1122 for Covid-19
DiUS FDA approves Oyster Point Pharma's nasal spray for dry eye disease
DiEMA approves two new sites for making Pfizer-BioNTech's Covid-19 vaccine
18.10.US FDA's VRBPAC recommends J&J Covid-19 vaccine booster shot
18.10.Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics
15.10.Exelixis, STORM partner to develop novel drug leads to treat cancer
14.10.Intellia Therapeutics and SparingVision enter strategic collaboration to develop ocular therapies
14.10.US FDA and EMA accept application for Novartis' Beovu to treat DME
13.10.Poseida, Takeda partner to develop eight in vivo gene therapy programmes
12.10.Pacira BioSciences to buy Flexion Therapeutics
11.10.Brii Biosciences files application for EUA for BRII-196/BRII-198 therapy in US
08.10.Enzolytics, Samsung Biologics partner to develop therapies for HIV, Covid-19
07.10.AstraZeneca's Alexion concludes Caelum acquisition for $500m
06.10.AstraZeneca seeks FDA EUA for antibody cocktail to prevent Covid-19
05.10.Australia signs agreement for new Covid-19 drug
04.10.Kite gets US FDA approval for Tecartus to treat acute lymphoblastic leukemia
01.10.Merck signs agreement to buy Acceleron Pharma for $11.5bn
01.10.Trevena reports positive results of TRV027 proof-of-concept trial in Covid-19 patients
30.09.AstraZeneca to acquire remaining stake in Caelum Biosciences
30.09.Appili, AiPharma partner to advance Avigan/Reeqonus global development
29.09.Japanese health ministry approves AstraZeneca's Saphnelo for systemic lupus erythematosus
28.09.Incyte and Syndax to jointly develop and commercialise axatilimab